ASO THERAPEUTICS, INC. — Department of Health and Human Services SBIR: FY2025 SBIR CONCEPT CLEARANCE AWARD OR TOPIC DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TE
ASO THERAPEUTICS, INC. — SBIR award from Department of Health and Human Services.
SBIR award competitive context
- Public SBIR obligation from Department of Health and Human Services to ASO THERAPEUTICS, INC.. Use agency + tech-domain links below to map the broader competitive field.
- Obligated amount $299,991. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
ASO Therapeutics, Inc. received nearly $300,000 from NIH for an SBIR award focused on developing new treatments or prevention methods for pediatric and rare cancers. This early-stage funding helps small businesses explore therapeutic technologies in this medical area.
- Amount
- $299,991
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- CA
- Period
- 2025-09-15 → 2027-09-14
Technology domains
Description
FY2025 SBIR CONCEPT CLEARANCE AWARD OR TOPIC DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS